ECHO 2: Initial Assessment of a Person Presenting for Weight Management - Live

Registration for this live ECHO is capped - please register for the on-demand webinar. 

Each ECHO will have a live and on-demand component; please note that participation in the live event is limited to 25 persons per event and that those who participate in the live ECHO may receive credit from the live event but are not eligible to also receive credit for the on-demand webinar. 

Endocrine Society is pleased to participate in Project ECHO: Approaches to Long-Term Weight Loss and Obesity Care webinar series. The second ECHO, featuring Dr. Jonathan Purnell, will focus on the initial assessment and evaluation of a person presenting for weight management. The live ECHO will take place on Tuesday, August 25, 2020 at 4pm PT // 5pm MT //  6pm CT // 7pm ET.

The CME evaluation will be available for the live course until September 1st, at which point the enduring material will become available. Those who register for the live event but do not attend will have their registration transferred to the on-demand webinar.

Please note that to participate in this ECHO, you must complete registration for the Project ECHO program.

About this ECHO

At the end of the webinar, participants will be able to

  • Be able to take a weight history and identify potentially modifiable influencers of unwanted weight gain and obesity.
  • Be able to identify and screen for presence of obesity-related complications
  • Apply thresholds for weight, weight circumference, and presence of comorbidities to assign risk and develop treatment strategies including lifestyle, pharmacologic, and surgical approaches (alone or in combination)

Supporting Articles:

  1. Srivastava G, Kushner RF, Apovian CM. Use of the Historial Weight Trajectory to Guide an Obesity-Focused Patient Encounter. In: Feingold KR, Anawalt B, Boyce A, et al., eds. Endotext. South Dartmouth (MA)2000.
  2. Sharma AM, Kushner RF. A proposed clinical staging system for obesity. Int J Obes (Lond). 2009;33(3):289-295.
  3. Kyrou I, Randeva HS, Tsigos C, Kaltsas G, Weickert MO. Clinical Problems Caused by Obesity. In: Feingold KR, Anawalt B, Boyce A, et al., eds. Endotext. South Dartmouth (MA)2000.

Space is limited to 25 participants on the live webinar. Register today!

Unable to attend the live event? Register for the on-demand session here!

Target Audience

This program will be of substantial interest to endocrinologists and fellows caring for individuals with, or at risk for developing, obesity and associated diseases. Additionally, this program may be of interest to primary care professionals and advance practice professionals who treat patients with obesity.

Learning Objectives

At the end of the webinar, participants will be able to:

  • Be able to take a weight history and identify potentially modifiable influencers of unwanted weight gain and obesity.
  • Be able to identify and screen for presence of obesity-related complications
  • Apply thresholds for weight, weight circumference, and presence of comorbidities to assign risk and develop treatment strategies including lifestyle, pharmacologic, and surgical approaches (alone or in combination)

    Additional Information

    Target Audience: 
    Physician-in-practice
    Fellow
    Resident
    Clinical researcher
    Scientific researcher
    Educator/Teacher
    Pharmacist
    Nurse/Nurse practitioner
    Physician assistant
    Allied health professional
    Other
    Competency Area: 
    Patient Care and Procedural Skills
    Medical Knowledge
    Topic Area: 
    Obesity
    Level of Outcomes: 
    Level 1 (Participation)
    Level 2 (Satisfaction)
    Level 3A (Learning: Declarative Knowledge (Knows))
    Activity summary
    Available credit: 
    • 1.00 AMA PRA Category 1 Credits
    • 1.00 CME Certificate of Participation
    Course opens: 
    07/31/2020
    Course expires: 
    08/31/2020
    Rating: 
    5

    Faculty 

    Jonathan Purnell, MD
    Oregon Health and Science University

    STATEMENT OF INDEPENDENCE

    As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.

    DISCLOSURE POLICY

    The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

    The following faculty reported relevant financial relationships: Jonathan Purnell, MD - Self: Novo Nordisk, Advisor Board - Global Obesity Program. 

    Disclosure information for guest speakers is included in their individual recorded presentations.

    The following peer reviewers reported no relevant financial relationships: Beret A. Casey, MD

    Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

    DISCLAIMERS

    USE OF PROFESSIONAL JUDGMENT:
    The educational content in this activity relates to basic principles of diagnosis and therapy and does not substitute for individual patient assessment based on the health care provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient. Standards in medicine change as new data become available.

    DRUGS AND DOSAGES:

    When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.

    POLICY ON UNLABELED/OFF-LABEL USE:

    The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such “off-label” use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.

    PRIVACY AND CONFIDENTIALITY STATEMENT:

    The Endocrine Society will record learner’s personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.

    ACKNOWLEDGMENT OF COMMERCIAL SUPPORT:

    This educational activity is supported by an independent medical educational grant from Novo Nordisk Inc. 

    Accreditation Statement

    The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.

    The Endocrine Society designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credit can be claimed for the live webinar 8/26/2020 at 7:00pm ET through 8/31/2020 at 11:59pm ET.

    Available Credit

    • 1.00 AMA PRA Category 1 Credits
    • 1.00 CME Certificate of Participation

    Registration for this live ECHO is capped - please register for the on-demand webinar. 

    Each ECHO will have a live and on-demand component; please note that participation in the live event is limited to 25 persons per event and that those who participate in the live ECHO may receive credit from the live event but are not eligible to receive credit for the on-demand webinar. 

    To access the case submission portal and Zoom information:

    • Click 'Start'
    • Complete the short pre-survey
    • Click into the case submission portal and upload your case and questions
    • Click into Zoom information to get instructions for access the webinar on 8/26